RUNX1 and inv(16) are frenemies in AML. Blood 2020 Nov 19;136(21):2361-2362
Date
11/20/2020Pubmed ID
33211836Pubmed Central ID
PMC7685212DOI
10.1182/blood.2020008802Scopus ID
2-s2.0-85096457850 (requires institutional sign-in at Scopus site) 1 CitationAbstract
In this issue of Blood, Zhen et al provide novel molecular insights into the requirement for Runx1 in a mouse model of inv(16) acute myeloid leukemia (AML).
Author List
Rao SAuthor
Sridhar Rao MD, PhD Associate Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Core Binding Factor Alpha 2 SubunitHumans
Leukemia, Myeloid, Acute
Myeloid Progenitor Cells
